-
A comparison of breast cancer survival across different age groups: a multicentric database study in Penang, Malaysia
-
King Fang Tan, Farzaana Adam, Hasmah Hussin, Noor Mastura Mohd Mujar
-
Epidemiol Health. 2021;43:e2021038. Published online May 25, 2021
-
DOI: https://doi.org/10.4178/epih.e2021038
-
-
15,432
View
-
393
Download
-
15
Web of Science
-
14
Crossref
-
 Abstract
Summary
 PDF
-
Abstract
This study compared breast cancer survival and the prognostic factors across different age groups of women in Penang, Malaysia. Data on 2,166 women with breast cancer who had been diagnosed between 2010 and 2014 were extracted from the Penang Breast Cancer Registry and stratified into 3 age groups: young (< 40 years old), middle-aged (40-59 years old), and elderly (≥ 60 years). The overall and relative survival rates were calculated using the life table method, median survival time was calculated using the Kaplan-Meier method, and comparisons between groups were conducted using the log-rank test. Prognostic factors were analyzed using a Cox proportional hazards model. The 5-year overall and breast cancer-specific survival rates for women with breast cancer in Penang were 72.9% and 75.2%, with a mean survival time of 92.5 months and 95.1 months, respectively. The 5-year breast cancer-specific survival rates for young, middle-aged, and elderly women were 74.9%, 77.8%, and 71.4%, respectively, with a mean survival time of 95.7 months, 97.5 months, and 91.2 months. There was a significant difference in breast cancer survival between age groups, with elderly women showing the lowest survival rate, followed by young and middle-aged women. Disease stage was the most prominent prognostic factor for all age groups. Survival rates and prognostic factors differed according to age group. Treatment planning for breast cancer patients should be age-specific to promote better cancer care and survival.
-
Summary
Key Message
The relationship between breast cancer survival and age at diagnosis has been explored, but information between survival at different age groups remains unclear, in addition to conflicting study results. This multicentre study was conducted to compare breast cancer survival across different age groups in an Asian setting.
-
Citations
Citations to this article as recorded by  - Illuminating the breast cancer survival rates among Southeast Asian women: A systematic review and meta-analysis spanning four decades
Duc Tran Quang, Thanh Luong Thi, Khanh Nguyen Di, Chi Vu Thi Quynh, Huyen Nguyen Thi Hoa, Quang Phan Ngoc
Current Problems in Cancer.2024; 48: 101062. CrossRef - Clinical characteristics and prognostic factors of male breast cancer in China
Han Lei, Baojie Hua, Yingying Mao, Wei Cui, Caiping Mao, Shaoxue Yang, Jiayu Li
Frontiers in Oncology.2024;[Epub] CrossRef - Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics
Yu-Tung Teng, Yong Alison Wang, Yaa-Hui Dong, Jason J. Liu
Breast Cancer Research and Treatment.2024; 205(3): 619. CrossRef - Demographic and Clinical Characteristics of Females with Breast Cancer in Iraq with Respect to Age: A Single-Center Study
Tahseen Alrubai, Rasha Zaki, Arwa Mohsun, Ali Mohammed, Loubna Sinno, Nabih Lawand, Samaa AL Tabbah
Forum of Clinical Oncology.2024;[Epub] CrossRef - Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities
Barathan Muttiah, Sook Luan Ng, Yogeswaran Lokanathan, Min Hwei Ng, Jia Xian Law
Pharmaceutics.2024; 16(5): 654. CrossRef - Epidemiology of Cancer in Older Adults: A Systematic Review
Sophie Pilleron, Esther Bastiaannet
Current Oncology Reports.2024; 26(9): 1021. CrossRef - “Sexual sacrifice”: a qualitative exploration of husbands’ experience of living with survivors of breast cancer—sexual dysfunction in Malaysia
Mohd Najman Abd Wahid, Rosediani Muhamad, Noraini Mohamad, Nani Draman
Supportive Care in Cancer.2024;[Epub] CrossRef - Cancer–related symptoms among young and middle–aged women undergoing chemotherapy for breast cancer: Application of latent class analysis and network analysis
Tingting Cai, Tingting Zhou, Qingmei Huang, Fulei Wu, Feixia Ni, Changrong Yuan
European Journal of Oncology Nursing.2023; 63: 102287. CrossRef - myBeST—A Web-Based Survival Prognostic Tool for Women with Breast Cancer in Malaysia: Development Process and Preliminary Validation Study
Mohd Nasrullah Nik Ab Kadir, Suhaily Mohd Hairon, Najib Majdi Yaacob, Siti Norbayah Yusof, Kamarul Imran Musa, Maya Mazuwin Yahya, Seoparjoo Azmel Mohd Isa, Muhammad Hafizuddin Mamat Azlan, Imi Sairi Ab Hadi
International Journal of Environmental Research and Public Health.2023; 20(4): 2985. CrossRef - Clinical Features and Outcomes of Triple-Negative Breast Cancer Among Latin American Adolescents and Young Adults Compared to Middle-Aged and Elder Females: A Cohort Analysis Over 15 Years
Bryan Valcarcel, J. Smith Torres-Roman, Daniel Enriquez-Vera, Gabriel De-la-Cruz-Ku
Journal of Adolescent and Young Adult Oncology.2023; 12(5): 625. CrossRef - Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study
Tongchao Jiang, Haishuang Sun, Na Li, Tongcui Jiang
Journal of Cancer Research and Clinical Oncology.2023; 149(15): 13511. CrossRef - The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
Lijun Ma, Ailan Liu, Jinnan Gao, Haoliang Zhao
Open Life Sciences.2023;[Epub] CrossRef - A Metabolic Gene Signature to Predict Breast Cancer Prognosis
Jun Lu, Pinbo Liu, Ran Zhang
Frontiers in Molecular Biosciences.2022;[Epub] CrossRef - Development of Predictive Models for Survival among Women with Breast Cancer in Malaysia
Mohd Nasrullah Nik Ab Kadir, Najib Majdi Yaacob, Siti Norbayah Yusof, Imi Sairi Ab Hadi, Kamarul Imran Musa, Seoparjoo Azmel Mohd Isa, Balqis Bahtiar, Farzaana Adam, Maya Mazuwin Yahya, Suhaily Mohd Hairon
International Journal of Environmental Research and Public Health.2022; 19(22): 15335. CrossRef
|
KSE
